MINERVAX ApS: Financial statements 2023
CVR: 32673287
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2023. In 2023, the company reported a net result of EUR -27,077,000 compared with DKK -107,993,181 the year before. Equity in the 2023 report amounted to EUR 67,603,000. The solvency ratio was 80%.
- Profit/Loss
- EUR -27,077,000
- Equity
- EUR 67,603,000
- Total Assets
- EUR 84,525,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | -27.1 mio. EUR | 67.6 mio. EUR | - |
| 2022 | - | -98.2 mio. | -108 mio. | 304.7 mio. | 7 |
| 2021 | - | -57.8 mio. | -61.9 mio. | 98.7 mio. | 7 |
| 2020 | - | -16.8 mio. | -19.5 mio. | 156 mio. | 1 |
| 2019 | - | -25.9 mio. | -24.8 mio. | -29.7 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 9, 2023, Vincent Guy A. Brichard has joined the board of directors of MINERVAX ApS.
As of October 9, 2023, Tal Zvi Zaks has joined the board of directors of MINERVAX ApS.
As of October 9, 2023, is registered as an owner of MINERVAX ApS with an ownership share of 5%.
As of October 9, 2023, is registered as an owner of MINERVAX ApS with an ownership share of 15%.
MINERVAX ApS has published its annual report for 2022. Gross profit came to DKK -98,152,171, and the net result was DKK -107,993,181.
As of May 30, 2023, EY Godkendt Revisionspartnerselskab has been appointed auditor of MINERVAX ApS.
As of May 30, 2023, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 28 employees (2026). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.